SPK Acquisition Corp.
SPK
NASDAQ Capital Market10.30
USD
+0.04
- -
CIK
0001848097
ISIN
US8486511053
CUSIP
848651105
Return %
Stock
S&P500
1Y
3.31
26.53
3Y
-6.36
76.60
5Y
-6.36
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- Room 368 Shanghai People's Republic of China 200131
- IPO Date
- Jul 23, 2021
- CIK
- 0001848097
- Similar Companies
- Business
- SPK Acquisition Corp. operates as a blank check company whose sole purpose is to effect a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or assets; it focuses primarily on operating companies in Asia within the telecommunications, media and technology (TMT) sectors. Incorporated in 2020 and headquartered in Shanghai, China (Room 368, 302 Buwei 211 Fute North Road, China (Shanghai) Pilot Free Trade Zone), the company generates no operational revenue and maintains no employees or ongoing business activities beyond pursuing a de-SPAC transaction. SPK Acquisition priced its initial public offering of 5 million units at $10.00 per unit in June 2021, raising approximately $50 million in gross proceeds held in trust, with common stock and rights beginning separate trading shortly thereafter; in February 2022, it announced a merger agreement with Varian Biopharmaceuticals, Inc., a precision oncology firm developing aPKC inhibitors such as topical VAR-101 for basal cell carcinoma and oral VAR-102 for solid tumors, under which Varian Bio would merge into a SPK subsidiary and SPK would rebrand as Varian Biopharma, Inc., with the deal expected to close in Q2 2022. The proposed Varian merger terminated in December 2022 due to breaches by the target and failure to make a required trust extension payment, leading to stockholder approval of a brief deadline extension in September 2022 followed by full liquidation and dissolution effective December 30, 2022, with all outstanding public shares redeemed and cancelled as of December 29, 2022, at an estimated per-share rate of approximately $10.41 from trust assets. Following liquidation, SPK Acquisition Corp. no longer trades actively on Nasdaq under ticker SPK, with remaining securities marked as delisted and no further operational or strategic developments reported.